ArticleFrontiers in public health2025
Self-reported health as a predictor of cardiometabolic multimorbidity in Chinese older adults: a national cross-sectional study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The relationship between resistance exercise and cardiometabolic health: a cross-sectional analysis of the 1970 British cohort study.Sport sciences for health · 2026Article
- Comparative discriminatory performance of emerging endocrine-metabolic indices versus obesity indices for cardiometabolic multimorbidity in older adults: a cross-sectional study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While self-reported health (SRH) robustly predicts clinical outcomes, its quantitative association with cardiometabolic multimorbidity (CMM) remains insufficiently characterized, particularly within low- and middle-income countries (LMICs). Aims: We aimed to quantify the dose-response relationship between SRH and CMM prevalence among older adults in China and to identify key sociodemographic effect modifiers. Methods: Utilizing cross-sectional data from the 2018 Chinese Longitudinal Healthy Longevity Survey (CLHLS), we analyzed 9,762 participants aged ≥65 years (mean age 83.2 ± 11.3). SRH was categorized as good, neutral, or bad. CMM was defined as the presence of ≥2 conditions among coronary heart disease, stroke, diabetes, hypertension, or dyslipidemia. Multivariable-adjusted logistic regression assessed the SRH-CMM association. Stratified analyses evaluated effect modification by sex, age group, and residence (city/town/rural). Results: Declining SRH demonstrated a graded association with increased CMM prevalence. Compared to "good" SRH, "bad" SRH was associated with a four-fold elevated CMM risk [adjusted odds ratio (aOR) = 3.992, 95% confidence interval (CI): 3.425-4.652], while "neutral" SRH conferred a two-fold risk elevation (aOR = 2.063, 95% CI: 1.835-2.320). Each one-level deterioration in SRH was associated with more than a doubling of the odds (aOR = 2.009, Conclusions: SRH exhibits a strong, independent dose-dependent association with CMM burden in older adults, capturing cumulative biological aging beyond traditional biomarkers. Integrating SRH into clinical risk stratification may optimize preventive interventions for high-risk subgroups, particularly older city males and individuals reporting health deterioration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.